130 related articles for article (PubMed ID: 31870703)
21. Identification of E2F1 as a positive transcriptional regulator for delta-catenin.
Kim K; Oh M; Ki H; Wang T; Bareiss S; Fini ME; Li D; Lu Q
Biochem Biophys Res Commun; 2008 May; 369(2):414-20. PubMed ID: 18302937
[TBL] [Abstract][Full Text] [Related]
22. The E2F1-miRNA cancer progression network.
Knoll S; Emmrich S; Pützer BM
Adv Exp Med Biol; 2013; 774():135-47. PubMed ID: 23377972
[TBL] [Abstract][Full Text] [Related]
23. E2F1 apoptosis counterattacked: evil strikes back.
Pützer BM; Engelmann D
Trends Mol Med; 2013 Feb; 19(2):89-98. PubMed ID: 23219173
[TBL] [Abstract][Full Text] [Related]
24. E2F1 interactive with BRCA1 pathway induces HCC two different small molecule metabolism or cell cycle regulation via mitochondrion or CD4+T to cytosol.
Chen Q; Wang L; Jiang M; Huang J; Jiang Z; Feng H; Ji Z
J Cell Physiol; 2018 Feb; 233(2):1213-1221. PubMed ID: 28474358
[TBL] [Abstract][Full Text] [Related]
25. Intestine-specific homeobox (ISX) upregulates E2F1 expression and related oncogenic activities in HCC.
Wang SN; Wang LT; Sun DP; Chai CY; Hsi E; Kuo HT; Yokoyama KK; Hsu SH
Oncotarget; 2016 Jun; 7(24):36924-36939. PubMed ID: 27175585
[TBL] [Abstract][Full Text] [Related]
26. E2F1 in gliomas: a paradigm of oncogene addiction.
Alonso MM; Alemany R; Fueyo J; Gomez-Manzano C
Cancer Lett; 2008 May; 263(2):157-63. PubMed ID: 18334281
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.
Lee KH; Chen YL; Yeh SD; Hsiao M; Lin JT; Goan YG; Lu PJ
Oncogene; 2009 Sep; 28(38):3360-70. PubMed ID: 19597470
[TBL] [Abstract][Full Text] [Related]
28. ANKRD22 promotes progression of non-small cell lung cancer through transcriptional up-regulation of E2F1.
Yin J; Fu W; Dai L; Jiang Z; Liao H; Chen W; Pan L; Zhao J
Sci Rep; 2017 Jun; 7(1):4430. PubMed ID: 28667340
[TBL] [Abstract][Full Text] [Related]
29. In prostate cancer C/EBPalpha promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT.
Yin H; Lowery M; Glass J
Prostate; 2009 Jun; 69(9):1001-16. PubMed ID: 19347879
[TBL] [Abstract][Full Text] [Related]
30. HOXB13 contributes to G1/S and G2/M checkpoint controls in prostate.
Hamid SM; Cicek S; Karamil S; Ozturk MB; Debelec-Butuner B; Erbaykent-Tepedelen B; Varisli L; Gonen-Korkmaz C; Yorukoglu K; Korkmaz KS
Mol Cell Endocrinol; 2014 Mar; 383(1-2):38-47. PubMed ID: 24325868
[TBL] [Abstract][Full Text] [Related]
31. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.
Su F; He W; Chen C; Liu M; Liu H; Xue F; Bi J; Xu D; Zhao Y; Huang J; Lin T; Jiang C
Cell Death Dis; 2018 Feb; 9(2):233. PubMed ID: 29445134
[TBL] [Abstract][Full Text] [Related]
32. E2F1 death pathways as targets for cancer therapy.
Pützer BM
J Cell Mol Med; 2007; 11(2):239-51. PubMed ID: 17488475
[TBL] [Abstract][Full Text] [Related]
33. KDM4A Coactivates E2F1 to Regulate the PDK-Dependent Metabolic Switch between Mitochondrial Oxidation and Glycolysis.
Wang LY; Hung CL; Chen YR; Yang JC; Wang J; Campbell M; Izumiya Y; Chen HW; Wang WC; Ann DK; Kung HJ
Cell Rep; 2016 Sep; 16(11):3016-3027. PubMed ID: 27626669
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic factor EPC1 is a master regulator of DNA damage response by interacting with E2F1 to silence death and activate metastasis-related gene signatures.
Wang Y; Alla V; Goody D; Gupta SK; Spitschak A; Wolkenhauer O; Pützer BM; Engelmann D
Nucleic Acids Res; 2016 Jan; 44(1):117-33. PubMed ID: 26350215
[TBL] [Abstract][Full Text] [Related]
35. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
[TBL] [Abstract][Full Text] [Related]
36. The E2F family and the role of E2F1 in apoptosis.
Wu Z; Zheng S; Yu Q
Int J Biochem Cell Biol; 2009 Dec; 41(12):2389-97. PubMed ID: 19539777
[TBL] [Abstract][Full Text] [Related]
37. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
Ofir M; Hacohen D; Ginsberg D
Mol Cancer Res; 2011 Apr; 9(4):440-7. PubMed ID: 21454377
[TBL] [Abstract][Full Text] [Related]
38. E2F1-induced upregulation of long noncoding RNA LINC00668 predicts a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically silencing of CKIs.
Zhang E; Yin D; Han L; He X; Si X; Chen W; Xia R; Xu T; Gu D; De W; Guo R; Xu Z; Chen J
Oncotarget; 2016 Apr; 7(17):23212-26. PubMed ID: 27036039
[TBL] [Abstract][Full Text] [Related]
39. Regulation of E2F1 by the von Hippel-Lindau tumour suppressor protein predicts survival in renal cell cancer patients.
Mans DA; Vermaat JS; Weijts BG; van Rooijen E; van Reeuwijk J; Boldt K; Daenen LG; van der Groep P; Rowland BD; Jans JJ; Roepman R; Voest EE; van Diest PJ; Verhaar MC; de Bruin A; Giles RH
J Pathol; 2013 Sep; 231(1):117-29. PubMed ID: 23744542
[TBL] [Abstract][Full Text] [Related]
40. miR-135a promotes gastric cancer progression and resistance to oxaliplatin.
Yan LH; Chen ZN; Li-Li ; Chen J; Wei WE; Mo XW; Qin YZ; Lin Y; Chen JS
Oncotarget; 2016 Oct; 7(43):70699-70714. PubMed ID: 27683111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
